ClinicalTrials.gov research records

ClinicalTrials.gov research-record snapshot for Akron, OH

Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on July 9, 2026 at 9:44 PM (UTC−07:00). The fixed source query returned 1 result; after an exact city/state check of listed facilities, 1 record were retained for Akron, Ohio. It is not a clinic, enrollment, or local-availability directory.

Snapshot methodology and exact-location matching

City/state source filter: Akron, Ohio
Exact-location inclusion rule: A listed facility city and state must match Akron, Ohio.

Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.

Fixed query terms

semaglutide
tirzepatide
cagrilintide
retatrutide
tesamorelin
sermorelin
ipamorelin
bpc-157
thymosin alpha 1
pt-141

Included study statuses

RECRUITING
NOT_YET_RECRUITING
ACTIVE_NOT_RECRUITING
ENROLLING_BY_INVITATION

How to read this snapshot

Research-record limits

This is not a clinic, enrollment, local-service, or local-availability directory.
Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
Each displayed registry status is a study-level overall status, not a facility enrollment status.
Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
Records are a fixed snapshot, not a complete or live catalog.

All retained records

Study-level status mix

The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.

RECRUITING: 1 record
NOT_YET_RECRUITING: 0 records
ACTIVE_NOT_RECRUITING: 0 records
ENROLLING_BY_INVITATION: 0 records

Records in this snapshot

Retained ClinicalTrials.gov NCT records

The retrieved source snapshot contains 1 exact-location record and 1 listed facility. All 1 retained records are shown below.

NCT07165028

Registry title: A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Study-level overall status: RECRUITING
Record update date: July 7, 2026

Exact-matched listed facility/location

Akron Gastro ResearchAkron, Ohio 44320

Source retrieval and snapshot limits

Source-query results versus exact-location records

At retrieval, the fixed ClinicalTrials.gov source query returned 1 result. After an exact city/state check of listed facilities, 1 record were retained for Akron, Ohio, across 1 listed facility. All 1 retained records are shown on this page.

Source retrieved: July 9, 2026 at 9:44 PM (UTC−07:00)
Record update dates: Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Source-query results: 1
Exact-location records retained: 1
Listed facilities retained: 1
Records shown: 1 of 1

Fixed ClinicalTrials.gov source query (JSON) Broader live ClinicalTrials.gov search (no status filter)

Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.

Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.